Fig. 14

Best treatment effect obtained in intramuscular K and KL tumours in immunocompetent mice: KRAS^G12D (A) and KRAS^G12D/LKB1^del (B) tumor volumes on days 35 and 31 of treatment respectively, the time-point when treatment benefit was greatest. Two-way ANOVA was used for statistical analysis (*p < 0.05, **p < 0.01, **** p < 0.0001). Error bars indicate SEM